NCBIO Life Science Forum - Reshaping How We Treat Disease January 2019
We have added an overflow room to accommodate additional registrants. Please note that seating in the main room will be on a first come first serve basis. If more than 2-3 are registered from a single organization, please have additional colleagues use the overflow room.
There are several new therapies that are reshaping the way we treat disease. Come hear leaders discuss their cutting-edge technologies in gene therapy, cell therapy, gene editing, and nanotechnology. Speakers will discuss how these therapies work, what companies need to succeed, and pricing/reimbursement models. Confirmed speakers include:
- Michael Dombeck, Vice President of Business Development, Precision BioSciences
- Tom Jede, Site Head and Senior Director, Vector Manufacturing, bluebird bio
- Susan Nichols, Chief Executive Officer, Falcon Therapeutics
- Alden Pritchard, Chief Executive Officer, Kaio Therapy
- Moderator to be added.